Batavia Biosciences is your flexible partner to rely on at all stages of biopharmaceutical process development. We aim to significantly contribute to ease human suffering from infectious disease and cancer by improving the success rate in the translation of candidate medicines from discovery to the clinic. We offer our novel technologies and in-depth know-how in order to help our partners to complete preclinical phases in biopharmaceutical product development at higher speed, reduced cost and increased success. The company focuses on the early stages of product development including mammalian cell line generation, upstream process development, purification development, product characterization and clinical manufacturing (cGMP). Headquartered in Leiden, The Netherlands, with a US-based facility in Woburn, Massachusetts, and offices in Hong Kong, Batavia Biosciences is privileged to have strong strategic partners worldwide.
Live Webinar taking place
Thursday 29th October 2020, 15:00 - 16:00 GMT
Register for the webinar that includes three short presentations on Spatial Biology and one narrated poster. The illustrious presenters will share interesting insights on how to uncover biomarkers in situ and how to deconvolute scRNA data and spatial profiling results in situ.